19th June 2026, Friday

TechPharus

Latest Posts

HealthTech News

  • Targeting enzyme could block cancer spread to brain with fewer side effects
    on June 19, 2026 at 5:00 pm

    A new study has identified a more precise and effective way to prevent cancer from spreading to the brain. The paper, published in the Proceedings of the National Academy of Sciences, details the development of novel drug candidates that target a key enzyme implicated in the spread of lung, breast, skin and other cancers to the brain. The work builds on a promising new therapeutic strategy first reported by the same group of researchers last year.

  • MAP1B reveals unexpected role for cytoskeletal proteins in brain development
    on June 19, 2026 at 4:20 pm

    The cytoskeleton gives cells their shape and helps them move. Researchers at Helmholtz Munich and Ludwig Maximilian University now show that, in neural stem cells, proteins of the cytoskeleton are also found in the cell nucleus, where they can influence developmental programs.

  • One gene deletion tears off colon cancer’s invisibility cloak, boosting immunotherapy
    on June 19, 2026 at 4:00 pm

    A study from the University of Calgary shows that removing a single gene makes colon cancer cells a target for immunotherapy—a fundamental breakthrough. The research, published in Cell Reports Medicine, was led by Dr. Arshad Ayyaz, Ph.D., an assistant professor in the Department of Biological Sciences and a member of the Arnie Charbonneau Cancer Institute.

  • Quick optical biopsy could be early detection method for endometrial cancer
    on June 19, 2026 at 3:40 pm

    Endometrial cancer is the most common gynecologic cancer, with more than 69,000 cases diagnosed in the U.S. in 2025 and increasing by up to 3% annually. Diagnosis requires an often painful, invasive biopsy that carries a risk of false negatives.

  • A renewable cell source for cancer immunotherapy could make off-the-shelf treatments possible
    on June 19, 2026 at 3:00 pm

    In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help drive the body’s response against pathogens, and they hold strong promise as the basis for immunotherapies against cancer and other diseases.